| Serial Number | 98648435 |
| Word Mark | ONTELRIQ |
| Filing Date | Monday, July 15, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 4, 2025 |
| Goods and Services | Pharmaceutical preparations for treating cancer, oncological diseases, rare diseases, namely, growth disorders, bone diseases, musculoskeletal diseases, namely, fibrodysplasia ossificans progressiva, connective tissue diseases, spinal cord diseases, fractures, sprains, cartilage injuries, rare chronic liver diseases and cholestatic diseases, liver diseases, respiratory diseases, cardiovascular diseases, immune disorders, namely autoimmune diseases, chronic liver diseases, gastrointestinal diseases, metabolic diseases, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia, inflammatory diseases, namely, enteric disease and connective tissue inflammation, urological diseases, disorders and diseases of the genitourinary system, namely, infertility, urovaginal infections, bladder disorders and sexually transmitted diseases, diseases and disorders of precocious puberty, gynecological disorders, to stimulate human fertility, for the treatment of acromegaly and malignant tumors, hormonal disorders, endocrine system disorders, namely, growth and thyroid gland disorders, connective tissue diseases, blood disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, namely, brain injuries, spinal cord injuries, epileptic disorders, Alzheimer's disease, Huntington's disease and cerebral palsy, musculoskeletal disorders, bone diseases, neuromuscular disorders, namely, muscular dystrophy, muscle dystonias and cervical dystonia, cerebral palsy, muscle spasticity, blepharospasm, migraine, for the treatment of pain, for the treatment of glabellar lines, facial wrinkles, for the treatment and prevention of skin diseases, facial asymmetry |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 15, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ipsen Pharma |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Boulogne-Billancourt 92100 FR |
| Party Name | Ipsen Pharma |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Boulogne-Billancourt 92100 FR |
| Event Date | Event Description |
| Monday, July 15, 2024 | NEW APPLICATION ENTERED |
| Monday, July 15, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 17, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 17, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, January 17, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 31, 2024 | ASSIGNED TO EXAMINER |
| Friday, January 24, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 11, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 11, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 11, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 11, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 11, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, February 26, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 4, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 4, 2025 | PUBLISHED FOR OPPOSITION |